OJPed  Vol.3 No.3 , September 2013
Is there a gender difference in antidiuretic response to desmopressin in children?
Abstract: Women with nocturia are more sensitive to desmopressin, a synthetic arginine vasopressin (AVP) analogue, with significant antidiuretic responses to desmopressin orally disintegrating tablet (ODT) 25 μg, compared with men who require 58 μg to achieve similar responses. In children the current desmopressin dose recommendation to treat primary nocturnal enuresis (PNE) is the same for boys and girls. This post hoc analysis of data from a randomised, doubleblind single-dose study of 84 children with PNE aged 6 - 12 years explored gender differences in sensitivity to desmopressin in children. Following water loading to suppress endogenous AVP, placebo or desmopres-sin 30, 60, 120, 240, 360 or 480 μg was administered when urinary production reached >0.13 mL/min/kg. The endpoints of urinary osmolality and duration of urinary-concentrating action (DOA) (above three thresholds: 125, 200 and 400 mOsm/kg) were analysed to compare efficacy in boys and girls, in each treatment group. The DOA and urinary osmolality were similar in both genders in the desmopressin 120 - 480 μg groups. Boys receiving desmopressin ODT 30 - 60 μg tended to increased urinary osmolality and experienced 1 - 2 hours longer DOA than girls. The same pattern of higher values in boys compared with girls was seen for all measures of urinary osmolality. Conclusion: In a limited sample of pre-pubertal children the antidiuretic response to desmopressin was largely similar between genders, in contrast to findings in adults.
Cite this paper: Juul, K. , Goble, S. , Bruyne, P. and Walle, J. (2013) Is there a gender difference in antidiuretic response to desmopressin in children?. Open Journal of Pediatrics, 3, 224-230. doi: 10.4236/ojped.2013.33039.

[1]   Lose, G., Lalos, O., Freeman, R.M. and van Kerrebroeck, P. (2003) Efficacy of desmopressin (Minirin) in the treatment of nocturia: A double-blind placebo-controlled study in women. American Journal of Obstetrics & Gynecology, 189, 1106-1113. doi:10.1067/S0002-9378(03)00593-3

[2]   Mattiasson, A., Abrams, P., van Kerrebroeck, P., Walter, S. and Weiss, J. (2002) Efficacy of desmopressin in the treatment of nocturia: A double-blind placebo-controlled study in men. BJU International, 89, 855-862. doi:10.1046/j.1464-410X.2002.02791.x

[3]   Weiss, J.P., Zinner, N.R., Klein, B.M. and N?rgaard, J.P. (2012) Desmopressin orally disintegrating tablet effectively reduces nocturia: Results of a randomized, doubleblind, placebo-controlled trial. Neurourology and Urodynamics, 31, 441-447. doi:10.1002/nau.22243

[4]   Juul, K.V., Klein, B.M., Sandstrom, R., Erichsen, L. and Norgaard, J.P. (2011) Gender difference in antidiuretic response to desmopressin. American Journal of Physiology—Renal Physiology, 300, F1116-F1122. doi:10.1152/ajprenal.00741.2010

[5]   Yamaguchi, O., Nishizawa, O., Juul, K.V. and Norgaard, J.P. (2013) Gender difference in efficacy and dose response in Japanese patients with nocturia treated with four different doses of desmopressin orally disintegrating tablet in a randomized, placebo-controlled trial. BJU International, 111, 474-484. doi:10.1111/j.1464-410X.2012.11547.x

[6]   Juul, K.V., Klein, B.M. and Norgaard, J.P. (2012) Longterm durability of the response to desmopressin in female and male nocturia patients. Neurourology and Urodynamics, 32, 363-370. doi:10.1002/nau.22306

[7]   Rittig, S., Knudsen, U.B., Norgaard, J.P., Pedersen, E.B. and Djurhuus, J.C. (1989) Abnormal diurnal rhythm of plasma vasopressin and urinary output in patients with enuresis. American Journal of Physiology, 256, F664-F671.

[8]   Yeung, C.K., Sreedhar, B., Sihoe, J.D., Sit, F.K. and Lau, J. (2006) Differences in characteristics of nocturnal enuresis between children and adolescents: A critical appraisal from a large epidemiological study. BJU International, 97, 1069-1073. doi:10.1111/j.1464-410X.2006.06074.x

[9]   Rittig, S., Schaumburg, H.L., Siggaard, C., Schmidt, F. and Djurhuus, J.C. (2008) The circadian defect in plasma vasopressin and urine output is related to desmopressin response and enuresis status in children with nocturnal enuresis. The Journal of Urology, 179, 2389-2395. doi:10.1016/j.juro.2008.01.171

[10]   Hancock, M.L., Bichet, D.G., Eckert, G.J., Bankir, L., Wagner M.A. and Pratt, J.H. (2010) Race, sex, and the regulation of urine osmolality: Observations made during water deprivation. American Journal Physiology—Regulatory Integrative and Comparative Physiology, 299, R977-R980. doi:10.1152/ajpregu.00289.2010

[11]   Hvistendahl, G.M., Riis, A., Norgaard, J.P. and Djurhuus, J.C. (2005) The pharmacokinetics of 400 microg of oral desmopressin in elderly patients with nocturia, and the correlation between the absorption of desmopressin and clinical effect. BJU International, 95, 804-809. doi:10.1111/j.1464-410X.2005.05405.x

[12]   Stachenfeld, N.S., Gleim, G.W., Zabetakis, P.M. and Nicholas, J.A. (1996) Fluid balance and renal response following dehydrating exercise in well-trained men and women. European Journal of Applied Physiology and Occupational Physiology, 72, 468-477. doi:10.1007/BF00242277

[13]   Weiss, J.P., Bosch, J.L., Drake, M., Dmochowski, R.R., Hashim, H., Hijaz, A., Johnson, T.M., Juul, K.V., Norgaard, J.P., Norton, P., Robinson, D., Tikkinen, K.A., van Kerrebroeck, P.E. and Wein, A.J. (2012) Nocturia think tank: Focus on nocturnal polyuria: ICI-RS 2011. Neurourology and Urodynamics, 31, 330-339. doi:10.1002/nau.22219

[14]   Vande Walle, J.G., Bogaert, G.A., Mattsson, S., Schurmans, T., Hoebeke, P., Deboe, V. and Norgaard, J.P. (2006) A new fast-melting oral formulation of desmopressin: A pharmacodynamic study in children with primary nocturnal enuresis. BJU International, 97, 603-609. doi:10.1111/j.1464-410X.2006.05999.x

[15]   Osterberg, O., Savic, R.M., Karlsson, M.O., Simonsson, U.S., Norgaard, J.P., Vande Walle, J. and Agerso, H. (2006) Pharmacokinetics of desmopressin administrated as an oral lyophilisate dosage form in children with primary nocturnal enuresis and healthy adults. The Journal of Clinical Pharmacology, 46, 1204-1211. doi:10.1177/0091270006291838

[16]   Wang, Y.X., Crofton, J.T., Liu, H., Brooks, D.P. and Share, L. (1994) Effects of gonadectomy on sexually dimorphic antidiuretic action of vasopressin in conscious rats. American Journal of Physiology—Regulatory, Integrative and Comparative Physiology, 267, R536-R541.

[17]   Wang, Y.X., Crofton, J.T., Miller, J., Sigman, C.J., Liu, H., Huber, J.M., Brooks, D.P. and Share, L. (1996) Sex difference in urinary concentrating ability of rats with water deprivation. American Journal of Physiology—Regulatory, Integrative and Comparative Physiology, 270, R550-R555.

[18]   Wang, Y.X., Crofton, J.T. and Share, L. (1997) Sex differences in the cardiovascular and renal actions of vasopressin in conscious rats. American Journal of Physiology—Regulatory, Integrative and Comparative Physiology, 272, R370-R376.

[19]   Wang, Y.X., Edwards, R.M., Nambi, P., Stack, E.J., Pullen, M., Share, L., Crofton, J.T. and Brooks, D.P. (1993) Sex difference in the antidiuretic activity of vasopressin in the rat. American Journal of Physiology—Regulatory, Integrative and Comparitive Physiology, 265, R1284-R1290.

[20]   Liu, J., Sharma, N., Zheng, W., Ji, H., Tam, H., Wu, X., Manigrasso, M.B., Sandberg, K. and Verbalis, J.G. (2011) Sex differences in vasopressin V(2) receptor expression and vasopressin-induced antidiuresis. American Journal of Physiology—Renal Physiology, 300, F433-F440. doi:10.1152/ajprenal.00199.2010

[21]   Stachenfeld, N. and Keefe, D.L. (2002) Estrogen effects on osmotic regulation of AVP and fluid balance. American Journal of Physiology—Endocrinology and Metabolism, 283, E711-E721.

[22]   Schoeftner, S., Blanco, R., Lopez de Silanes, I., Muaoz, P., Gómez-López, G., Flores, J.M. and Blasco, M.A. (2009) Telomere shortening relaxes X chromosome inactivation and forces global transcriptome alterations. Proceedings of the National Academy of Sciences of the United States of America, 106, 19393-19398. doi:10.1073/pnas.0909265106

[23]   Yang, F., Babak, T., Shendure, J. and Disteche, C.M. (2010) Global survey of escape from X inactivation by RNA-sequencing in mouse. Genome Research, 20, 614-622. doi:10.1101/gr.103200.109

[24]   Norgaard, J.P., Pedersen, E.B. and Djurhuus, J.C. (1985) Diurnal anti-diuretic-hormone levels in enuretics. Journal of Urology, 134, 1029-1031.

[25]   Gentilini, D., Castaldi, D., Mari, D., Monti, D., Franceschi, C., Di Blasio, A.M. and Vitale, G. (2012) Agedependent skewing of X chromosome inactivation appears delayed in centenarians’ offspring. Is there a role for allelic imbalance in healthy aging and longevity? Aging Cell, 11, 277-283. doi:10.1111/j.1474-9726.2012.00790.x

[26]   Migeon, B.R. (2008) X inactivation, female mosaicism, and sex differences in renal diseases. Journal of the American Society of Nephrology, 19, 2052-2059. doi:10.1681/ASN.2008020198

[27]   Demura, M., Takeda, Y., Yoneda, T., Oda, N., Bando, Y. and Mabuchi, H. (2004) Surgical stress-induced transient nephrogenic diabetes insipidus (NDI) associated with decreased vasopressin receptor2 (AVPR2) expression linked to nonsense-mediated mRNA decay and incomplete skewed X-inactivation in a female patient with a heterozygous AVPR2 mutation (c. 89-90 delAC). Clinical Endocrinology, 60, 773-775. doi:10.1111/j.1365-2265.2004.02042.x

[28]   Fjellestad-Paulsen, A., Wille, S. and Harris, A.S. (1987) Comparison of intranasal and oral desmopressin for nocturnal enuresis. Archives of Disease in Childhood, 62, 674-677. doi:10.1136/adc.62.7.674

[29]   Odeberg, J.M., Callréus, T., Lundin, S., Roth, E.B. and Hoglund, P. (2004) A pharmacokinetic and pharmacodynamic study of desmopressin: Evaluating sex differences and the effect of pre-treatment with piroxicam, and further validation of an indirect response model. Journal of Pharmacy and Pharmacology, 56, 1389-1398. doi:10.1211/0022357044535